Stock listing

BOATS:BOLD Boundless Bio, Inc. Stock

US listing (BOATS) of Boundless Bio, Inc. · home listing NASDAQ:BOLD

Follow Boundless Bio, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:BOLD

$2.32 USD -0.08 (-3.3%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BOLD

Past year +109.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.28 – $2.39 USDNov 20, 2026
Volume
147,867 sharesNov 20, 2026
Market cap
$53.61M USDAt the close on Nov 20, 2026 · price × 23.11M shares outstanding
52-week range
$0.961 – $3.16 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$344,109 USDMedian day 103,237 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Boundless Bio, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BOLD · Home$2.32 USD-0.08 (-3.3%)147,867$2.35$2.385$2.28$2.40Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BOLD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.32-0.08-3.3%$2.35$2.385$2.28147,867
$2.40-0.01-0.4%$2.43$2.43$2.38153,051
$2.410.000.0%$2.435$2.44$2.39106,039
$2.41-0.09-3.6%$2.50$2.50$2.40137,005
$2.50+0.04+1.6%$2.46$2.535$2.39156,469
$2.460.000.0%$2.45$2.47$2.41533,586
$2.46+0.01+0.4%$2.46$2.46$2.3910,831
$2.45-0.01-0.4%$2.46$2.50$2.40119,246
$2.460.000.0%$2.43$2.50$2.4329,958
$2.46+0.05+2.1%$2.41$2.52$2.3894,045
$2.41+0.01+0.4%$2.40$2.43$2.3871,073
$2.40+0.02+0.8%$2.41$2.45$2.40138,913
$2.38-0.06-2.5%$2.44$2.548$2.3856,080
$2.44-0.03-1.2%$2.48$2.50$2.4091,155
$2.47-0.01-0.4%$2.525$2.59$2.4347,014
$2.48-0.02-0.8%$2.51$2.543$2.45357,507
$2.50+0.09+3.7%$2.41$2.60$2.41246,010
$2.410.000.0%$2.41$2.43$2.3891,087
$2.41+0.05+2.1%$2.40$2.434$2.3659,100
$2.36-0.08-3.3%$2.41$2.44$2.34534,870
$2.440.000.0%$2.45$2.46$2.38114,063
$2.44+0.01+0.4%$2.53$2.565$2.4164,263
$2.43+0.12+5.2%$2.33$2.49$2.3389,739
$2.31-0.03-1.3%$2.38$2.485$2.31219,722
$2.34-0.01-0.4%$2.37$2.49$2.28711,179
$2.35-0.04-1.7%$2.40$2.525$2.335181,976
$2.39-0.04-1.6%$2.43$2.49$2.385129,823
$2.43-0.12-4.7%$2.55$2.69$2.39463,158
$2.55+0.02+0.8%$2.53$2.59$2.5060,474
$2.53-0.05-1.9%$2.58$2.64$2.47166,793
$2.58-0.06-2.3%$2.58$2.67$2.50334,164
$2.64+0.07+2.7%$2.58$2.71$2.562116,894
$2.57-0.03-1.2%$2.62$2.65$2.51565,184
$2.60-0.02-0.8%$2.62$2.66$2.5655,060
$2.62+0.03+1.2%$2.62$2.70$2.55156,529
$2.59+0.08+3.2%$2.49$2.62$2.49163,785
$2.51-0.05-2.0%$2.56$2.635$2.42208,241
$2.56-0.05-1.9%$2.60$2.62$2.5651,995
$2.61-0.05-1.9%$2.68$2.715$2.558142,237
$2.66+0.06+2.3%$2.61$2.67$2.59255,396
$2.60-0.10-3.7%$2.69$2.74$2.595550,321
$2.70-0.18-6.2%$2.89$2.89$2.685170,128
$2.88+0.05+1.8%$2.93$2.93$2.8330,246
$2.83+0.02+0.7%$2.80$2.835$2.75133,702
$2.81+0.01+0.4%$2.79$2.87$2.77346,379
$2.80-0.02-0.7%$2.83$2.83$2.7792,212
$2.82+0.01+0.4%$2.81$2.85$2.785102,234
$2.81-0.03-1.1%$2.83$2.85$2.8123,226
$2.84+0.01+0.4%$2.84$2.89$2.8429,828
$2.83-0.01-0.4%$2.85$2.85$2.8163,841
$2.84-0.01-0.4%$2.85$2.87$2.8228,654
$2.85-0.01-0.3%$2.86$2.878$2.8348,820
$2.86-0.01-0.3%$2.87$2.94$2.76168,003
$2.870.000.0%$2.87$2.89$2.8620,000
$2.87-0.02-0.7%$2.90$2.94$2.8572,441
$2.890.000.0%$2.89$2.91$2.8581,533
$2.89+0.08+2.8%$2.81$2.905$2.805146,028
$2.81-0.02-0.7%$2.81$2.94$2.80103,237
$2.83-0.03-1.0%$2.82$2.86$2.8075,542
$2.86-0.055-1.9%$2.91$2.99$2.8646,674
$2.915-0.025-0.9%$2.98$3.04$2.90158,800
$2.94-0.02-0.7%$2.96$3.00$2.9341,264
$2.96-0.04-1.3%$3.05$3.164$2.905118,477
$3.00+0.10+3.4%$2.91$3.02$2.91157,158
$2.90+0.04+1.4%$2.84$3.01$2.84218,735
Ticker
BOATS:BOLD
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Boundless Bio, Inc. news

Boundless Bio, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
9 in the last 12 months · 26 in all · newest Jun 23, 2026 · oldest 2024
Decks
1 deck · latest May 2026

Where Boundless Bio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BOLD · Home listingNASDAQUnited StatesUSD
BOATS:BOLD · This pageBOATSUnited StatesUSD

Valuation

Price/book 0.9× against a median of 0.9×: 4th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$9.28M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.9×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.65

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Boundless Bio, Inc. · NASDAQ:BOLDUS$53.61M−US$9.28Mn/an/an/a0.9×n/a0.0×0.65
EyeGene, Inc. · KRX:185490US$55.25MUS$26.51Mn/a8.0×n/a1.5×−391.5%0.0×n/a
AB Science SA · EURONEXT:ABUS$55.18MUS$50.53Mn/a39.2×n/an/a−132.6%n/an/a
Azora Therapeutics, Inc. · NASDAQ:AZRUS$55.00MUS$33.00Mn/an/an/an/an/an/a1.00
Island Pharmaceuticals Ltd · ASX:ILAUS$54.87MUS$46.34Mn/a248×n/a6.2×n/a0.0×n/a
Anavex Life Sciences Corp. · NASDAQ:AVXLUS$54.83M−US$63.50Mn/an/an/a0.5×n/a0.0×2.39
Nordicus Partners Corp · OTC:NORDUS$54.44MUS$54.44Mn/an/an/a0.9×n/a0.0×0.45
Xilio Therapeutics, Inc. · NASDAQ:XLOUS$53.40M−US$62.82Mn/a−1.1×n/a0.8×−20.9%0.1×0.76
Impact BioMedical, Inc. · AMEX:IBOUS$53.31MUS$53.29M33.0×1,402×n/a5.3×n/a0.0×0.06
XBiotech Inc. · NASDAQ:XBITUS$52.74M−US$52.29Mn/an/an/a0.4×n/a0.0×0.52
Bonus Biogroup Ltd. · TASE:BONSUS$52.22MUS$54.52Mn/an/an/an/an/an/an/a
Median of the othersUS$54.64MUS$39.67M33.0×39.2×0.9×−132.6%0.0×0.64

Forecasts

1 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
4.00 USD · Analysts' mean
EPS, year to Dec 2026
-1.71 · 1 analyst

Team and board

Officers

OfficerRole
Jessica OienChief Legal Officer
Angela PietrofesoVice President, Clinical Operations
David HinkleSenior Vice President, Finance & Controller
Jonathan LimChairman and Co-Founder
Meredith WesleyChief Human Resources Officer

Board

DirectorRole
Jonathan LimChairman and Co-Founder
James Jamie ChristensenDirector
Jennifer LewDirector
Nancy WhitingDirector

Events

QuarterResultsShare move
Q3 2026Nov 10, 2026 · Before open−0.4%
Q2 2026Aug 7, 2026−0.7%
Q1 2026May 8, 2026 · Before open−5.9%
Q4 2025Mar 26, 2026−1.8%
Q3 2025Nov 5, 2025 · Before open−3.1%
Q2 2025Aug 5, 2025 · Before open−1.7%
Q1 2025May 9, 2025 · Before open−4.0%
Q4 2024Mar 27, 2025−1.3%
Q3 2024Nov 7, 2024 · After close+5.4%
Q2 2024Aug 12, 2024 · After close+2.8%
All 12 quarters
QuarterResultsShare move
Q1 2024May 13, 2024 · Before open+10.8%
Q4 2023Feb 28, 2024

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (May 2026)Investor deck42 slidesMay 2026

Open Decks

IPO

Priced at US$16.00 a share on Mar 27, 2024.

Price
US$16.00 a share
Shares offered
6,250,000 shares of common stock
Offering size
US$100 million
Underwriters' option
Up to 937,500 more shares
Underwriters
Goldman Sachs & Co. LLC, Leerink Partners, Piper Sandler, Guggenheim Securities · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceSep 1, 2023
Filed publiclyMar 6, 2024
Amended onceMar 21, 2024
Shares registered with an exchangeMar 22, 2024
Declared effective by the SECMar 27, 2024
Final prospectus, with the priceMar 28, 2024

Open IPO · From the cover of the final prospectus (424B4) filed Mar 28, 2024

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2018FY2017FY2016
Revenue00000
Cost of revenue1.25M1.09M957.0K942.0K682.0K
Gross profit-1.25M-1.09M-957.0K-942.0K-682.0K
Research and development44.8M55.3M42.6M37.2M19.3M104.4M75.9M48.8M
Selling, general and administrative18.7M18.0M12.2M9.31M6.02M30.0M17.3M11.3M
Operating income-63.6M-73.3M-54.8M-46.5M-25.3M-134.4M-93.2M-60.0M
Depreciation and amortization1.25M1.09M957.0K942.0K682.0K7.46M3.75M1.58M
EBITDA-62.3M-72.2M-53.8M-45.5M-24.6M-126.9M-89.4M-58.5M
Income before tax-58.2M-65.4M-49.4M-45.9M-25.2M-128.8M-92.5M-59.7M
Income tax00-5.28M-668.0K-96.0K5.55M-2.25M378.0K
Net income-58.2M-65.4M-49.4M-45.9M-25.2M-128.8M-90.2M-59.7M
Earnings per share, basic-2.60-3.85-40.65-2.06-1.13-2.93-3.40-5.59
Earnings per share, diluted-2.60-3.85-40.65

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2018FY2017FY2016
Cash and equivalents17.9M26.6M23.7M11.0M34.3M144.3M39.0M36.4M
Short-term investments89.7M125.5M97.0M55.8M38.7M270.0M94.6M68.5M
Current assets109.6M154.4M124.2M68.0M74.6M419.8M137.0M108.4M
Property, plant and equipment3.22M4.32M2.57M
Goodwill3.63M3.63M3.63M
Total assets157.1M206.4M129.9M76.8M113.7M472.6M178.7M142.1M
Accounts payable1.49M1.27M2.22M1.40M1.07M8.12M3.85M2.42M
Current liabilities12.5M8.13M9.36M7.73M3.87M23.9M17.7M12.6M
Total debt49.0M47.6M2.19M5.18M377.0K7.07M7.18M2.75M
Total liabilities58.4M55.8M9.36M158.5M151.9M29.8M22.1M22.7M
Shareholders' equity98.7M150.6M-127.1M-81.7M-38.2M442.8M156.6M119.4M
Shares outstanding22.4M22.3M1.25K22.2M22.2M44.0M26.6M10.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2018FY2017FY2016
Cash from operations-46.7M-60.8M-46.9M-39.6M-23.2M-108.0M-84.5M-49.0M
Capital spending-546.0K-2.54M-633.0K-1.07M-2.03M-11.6M-7.55M-16.7M
Free cash flow-47.2M-63.4M-47.5M-40.7M-25.3M-119.6M-92.1M-65.7M
Cash from investing37.8M-26.1M-38.3M16.1M-59.3M-185.0M-33.4M-62.0M
Cash from financing141.0K89.8M97.9M126.0K105.5M398.5M120.6M75.4M
Share buybacks141.0K110.0K-144.3M-39.0M-36.4M
Change in cash-8.72M2.88M12.8M-23.3M23.0M105.4M2.61M-35.7M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 20, 2026Insider tradeSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveNov 4, 2026Other filingsSEC
424B3 · ProspectusNov 3, 2026Offer documentSEC
S-4/A · Registration statement, amendedOct 30, 2026Offer documentSEC
4 · Change in ownershipOct 29, 2026Insider tradeSEC
All 167 filings
FilingDateTypeFiled with
425Oct 26, 2026Other filingsSEC
4 · Change in ownershipOct 26, 2026Insider tradeSEC
425Oct 26, 2026Other filingsSEC
4 · Change in ownershipOct 20, 2026Insider tradeSEC
S-4 · Registration statementOct 8, 2026Offer documentSEC
DRS · Draft registration statementAug 31, 2026Offer documentSEC
425Aug 28, 2026Other filingsSEC
8-K · Current reportAug 28, 2026Material contractSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 27, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 7, 2026Quarterly reportSEC
4 · Change in ownershipJul 21, 2026Insider tradeSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJun 29, 2026Big-stake noticeSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 29, 2026Insider tradeSEC
425Jun 23, 2026Other filingsSEC
8-K · Current reportJun 23, 2026Material contractSEC
8-K · Current reportJun 17, 2026Meeting outcomeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
8-K · Current reportMay 8, 2026ResultsSEC
ARS · Annual report to shareholdersApr 28, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
8-K · Current reportApr 13, 2026FinancingSEC
10-K · Annual reportMar 9, 2026Annual reportSEC
8-K · Current reportMar 9, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeDec 4, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 5, 2025ResultsSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
8-K · Current reportJun 23, 2025Meeting outcomeSEC
8-K · Current reportMay 23, 2025Current reportSEC
10-Q · Quarterly reportMay 9, 2025Quarterly reportSEC
8-K · Current reportMay 9, 2025ResultsSEC
ARS · Annual report to shareholdersApr 29, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2025Meeting noticeSEC
EFFECT · Notice that a registration is effectiveApr 11, 2025Other filingsSEC
CORRESP · Letter to the SECApr 8, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 8, 2025Other filingsSEC
8-K · Current reportApr 1, 2025Material contractSEC
S-3 · Registration statementApr 1, 2025Offer documentSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
8-K · Current reportMar 27, 2025ResultsSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
3 · Initial statement of ownershipFeb 3, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
UPLOAD · Letter from the SECJan 23, 2025Other filingsSEC
8-K · Current reportDec 12, 2024Management or board changeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
SC 13D · Big-stake noticeOct 29, 2024Big-stake noticeSEC
3 · Initial statement of ownershipOct 15, 2024Insider tradeSEC
8-K · Current reportOct 15, 2024Management or board changeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
8-K · Current reportAug 20, 2024Management or board changeSEC
8-K · Current reportAug 12, 2024ResultsSEC
10-Q · Quarterly reportAug 12, 2024Quarterly reportSEC
4 · Change in ownershipJun 20, 2024Insider tradeSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
8-K · Current reportMay 13, 2024ResultsSEC
SC 13G · Big-stake noticeApr 12, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeApr 12, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeApr 10, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeApr 9, 2024Big-stake noticeSEC
4 · Change in ownershipApr 4, 2024Insider tradeSEC
4 · Change in ownershipApr 4, 2024Insider tradeSEC
4 · Change in ownershipApr 4, 2024Insider tradeSEC
4 · Change in ownershipApr 4, 2024Insider tradeSEC
4 · Change in ownershipApr 4, 2024Insider tradeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
8-K · Current reportApr 2, 2024Current reportSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
S-8 · Registration statement for employee plansMar 28, 2024Offer documentSEC
424B4 · ProspectusMar 28, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveMar 28, 2024Other filingsSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2024Insider tradeSEC
CERT · Exchange's certificate of listingMar 27, 2024Other filingsSEC
CORRESP · Letter to the SECMar 25, 2024Other filingsSEC
CORRESP · Letter to the SECMar 25, 2024Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeMar 22, 2024Other filingsSEC
S-1/A · Registration statement, amendedMar 21, 2024Offer documentSEC
CORRESP · Letter to the SECMar 15, 2024Other filingsSEC
UPLOAD · Letter from the SECMar 13, 2024Other filingsSEC
CORRESP · Letter to the SECMar 8, 2024Other filingsSEC
CORRESP · Letter to the SECMar 6, 2024Other filingsSEC
S-1 · Registration statementMar 6, 2024Offer documentSEC
UPLOAD · Letter from the SECJan 29, 2024Other filingsSEC
DRS/A · Draft registration statement, amendedJan 22, 2024Offer documentSEC
DRSLTR · Letter to the SEC with a draftOct 11, 2023Other filingsSEC
DRS/A · Draft registration statement, amendedOct 11, 2023Offer documentSEC
UPLOAD · Letter from the SECSep 29, 2023Other filingsSEC
DRS · Draft registration statementSep 1, 2023Offer documentSEC
DAug 14, 2023Other filingsSEC
DMay 4, 2021Other filingsSEC
DMar 12, 2020Other filingsSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Boundless Bio, Inc.’s releases

Common shares
23,108,935
Fully diluted
23,108,935

Fully diluted

LineShares
Common shares23,108,935

Share count over time

CountShares
Nov 22, 202623,108,935

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Tang Capital Management LLC2.84M12.5%US$7.13M+281KNov 16, 2026
ARCH Venture Management, LLC2.69M11.8%US$6.76MNo changeNov 16, 2026
Fidelity2.56M11.3%US$6.44M−16,700Nov 10, 2026
ADAR1 Capital Management, LLC1.89M8.3%US$4.75M−74,777Nov 16, 2026
Cormorant Asset Management, LP940K4.1%US$2.36M−60,000Nov 16, 2026
Vanguard716K3.1%US$1.8M+36,149Nov 13, 2026
Wellington556K2.4%US$1.4MNo changeNov 16, 2026
Renaissance Technologies494K2.2%US$1.24M+21,930Nov 12, 2026
Two Sigma375K1.7%US$942KNewNov 16, 2026
Acadian Asset Management LLC347K1.5%US$871K+200KNov 9, 2026
All 40 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Alyeska Investment Group, L.P.300K1.3%US$753KNo changeNov 16, 2026
China Universal Asset Management Co., Ltd.233K1.0%US$597K+216KOct 27, 2026
Superstring Capital Management LP206K0.91%US$518K+151KNov 16, 2026
RBF Capital, LLC200K0.88%US$502KNo changeNov 13, 2026
Citadel158K0.70%US$397K+13,214Nov 16, 2026
Ensign Peak Advisors, Inc134K0.59%US$335K−26,241Nov 12, 2026
Geode Capital130K0.57%US$325K+12,936Nov 6, 2026
State Street101K0.44%US$253K+84,700Nov 12, 2026
BlackRock85,7860.38%US$215K−2,709Nov 13, 2026
Bridgeway Capital Management, LLC77,5000.34%US$195K−50,500Nov 16, 2026
XTX Topco Ltd70,9120.31%US$178K+37,551Nov 16, 2026
Rangeley Capital, LLC68,0000.30%US$171K−6,000Nov 16, 2026
Marshall Wace, LLP54,0310.24%US$136KNewNov 13, 2026
Stonepine Capital Management, LLC52,5470.23%US$132K−102KNov 13, 2026
Spark Investment Management LLC45,8000.20%US$115KNewNov 13, 2026
Quadrature Capital Ltd44,8090.20%US$112KNewNov 13, 2026
Jane Street42,7370.19%US$107K−21,586Nov 12, 2026
Northern Trust34,8240.15%US$87,408No changeNov 16, 2026
Hrt Financial LP22,6080.10%US$56,000−93,680Nov 13, 2026
Axq Capital, LP14,8650.07%US$37,311NewNov 12, 2026
Millennium13,5090.06%US$33,908−465KNov 16, 2026
Pure Financial Advisors, LLC10,1000.04%US$25,351No changeNov 16, 2026
Morgan Stanley9,0000.04%US$22,590−4,000Nov 13, 2026
Caitong International Asset Management Co., Ltd8,1700.04%US$20,507−2,273Oct 29, 2026
JPMorgan1,169<0.01%US$2,993+990Nov 12, 2026
RBC244<0.01%US$1,000NewNov 16, 2026
Tower Research Capital LLC (TRC)77<0.01%US$194−271Nov 16, 2026
BNP Paribas58<0.01%US$146−118Nov 12, 2026
UBS2<0.01%US$5No changeNov 10, 2026
SBI Securities Co., Ltd.2<0.01%US$5No changeOct 21, 2026

Funds

HolderSharesOf the companyValueChangeAs of
Fidelity Growth Company Fund900K4.0%US$1.31MNo changeMay 31, 2026
Vanguard Total Stock Market Index Fund445K2.0%US$1.11MNo changeJun 30, 2026
Fidelity Growth Company K6 Fund226K1.00%US$328K−2,955May 31, 2026
Fidelity Series Growth Company Fund203K0.89%US$294K−30,800May 31, 2026
Vanguard Extended Market Index Fund152K0.67%US$380KNo changeJun 30, 2026
Fidelity Extended Market Index Fund82,6550.36%US$120K+14,943May 31, 2026
Ultra-Small Company Fund77,5000.34%US$194KNewJun 30, 2026
iShares Micro-Cap ETF58,8510.26%US$147K+16,413Jun 30, 2026
Ultra-Small Company Market Fund50,5000.22%US$126KNo changeJun 30, 2026
Vanguard Balanced Index Fund17,7310.08%US$44,328NewJun 30, 2026
All 13 holders
HolderSharesOf the companyValueChangeAs of
Fidelity Series Total Market Index Fund15,4110.07%US$22,346+4,442May 31, 2026
Fidelity Total Market Index Fund8,9460.04%US$12,972No changeMay 31, 2026
1290 VT Micro Cap Portfolio4,0890.02%US$10,223+1,128Jun 30, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Tang Kevin
10% owner
Buy10,707USD 2.40US$25,697Oct 27, 2026
Tang Kevin
10% owner
Buy9,606USD 2.38US$22,862Oct 26, 2026
Tang Kevin
10% owner
Buy6,234USD 2.38US$14,837Oct 23, 2026
Tang Kevin
10% owner
Buy5,800USD 2.40US$13,920Oct 22, 2026
Tang Kevin
10% owner
Buy220USD 2.37US$521Oct 20, 2026
Tang Kevin
10% owner
Buy12,790USD 2.34US$29,929Oct 19, 2026
Tang Kevin
10% owner
Buy18,279USD 2.33US$42,590Oct 19, 2026
Tang Kevin
10% owner
Buy118,185USD 2.34US$277KOct 16, 2026
Tang Capital Management LLC
10% owner
Sale18,300USD 2.97US$54,351Aug 26, 2026
Tang Kevin
10% owner
Buy2,975USD 2.44US$7,259Jul 21, 2026
All 33 trades
InsiderTradeSharesPriceValueDate
Tang Kevin
10% owner
Buy1,623USD 2.44US$3,960Jul 20, 2026
Tang Kevin
10% owner
Buy265USD 2.44US$647Jul 17, 2026
Tang Kevin
10% owner
Buy18,491USD 2.44US$45,118Jul 16, 2026
Tang Kevin
10% owner
Buy1,600USD 2.44US$3,904Jul 15, 2026
Tang Kevin
10% owner
Buy43,878USD 2.43US$107KJul 14, 2026
Tang Kevin
10% owner
Buy48,211USD 2.42US$117KJul 13, 2026
Tang Kevin
10% owner
Buy43,367USD 2.43US$105KJul 10, 2026
Tang Kevin
10% owner
Buy7USD 2.48US$17Jul 9, 2026
Tang Kevin
10% owner
Buy14,338USD 2.46US$35,271Jul 8, 2026
Tang Kevin
10% owner
Buy15,810USD 2.48US$39,209Jul 7, 2026
Tang Kevin
10% owner
Buy27,062USD 2.49US$67,384Jul 6, 2026
Tang Kevin
10% owner
Buy9,821USD 2.49US$24,454Jul 2, 2026
ARCH Venture Partners IX, L.P.
10% owner
Sale16,000USD 2.49US$39,840Jul 1, 2026
Steven Gillis
10% owner
Sale16,000USD 2.49US$39,840Jul 1, 2026
Tang Kevin
10% owner
Buy71,612USD 2.49US$178KJul 1, 2026
Tang Kevin
10% owner
Buy25,930USD 2.54US$65,862Jun 30, 2026
Tang Kevin
10% owner
Buy100USD 2.50US$250Jun 30, 2026
Tang Kevin
10% owner
Buy63,985USD 2.47US$158KJun 29, 2026
Tang Kevin
10% owner
Buy777USD 2.48US$1,927Jun 29, 2026
Tang Kevin
10% owner
Buy75,047USD 2.55US$191KJun 26, 2026
Tang Kevin
10% owner
Buy134USD 2.54US$340Jun 26, 2026
Tang Kevin
10% owner
Buy145,880USD 2.48US$362KJun 25, 2026
Tang Kevin
10% owner
Buy510USD 2.56US$1,306Jun 25, 2026

Big stakes

HolderStakeSharesDate
Tang Capital Management LLC12.50%2.84MSep 30, 2026
FMR LLC12.00%2.68MDec 31, 2025
Zachary Hornby9.80%2.43MOct 14, 2025
ADAR1 Capital Management, LLC8.80%1.97MJun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kristina Burow
Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Jan 30, 2025); Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Scholar Rock Holding Corporation (Director · Since at least May 23, 2018); Metacrine Inc (Director · Sep 15, 2020 – May 24, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Jun 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 21, 2020 · Past); Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 8, 2023 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Receptos Inc (Director · Aug 25, 2015 – Aug 25, 2015 · Past)
Director · Since at least Mar 27, 2024
Jennifer Lew
Other companies: Annexon, Inc. (EVP & CHIEF FINANCIAL OFFICER · Since at least Jul 23, 2020); Aduro Biotech Inc (Chief Financial Officer · Apr 14, 2015 – May 1, 2019 · Past); Dynavax Technologies Corporation (VP, Finance & PAO · Jan 31, 2012 – Feb 5, 2013 · Past)
Director · Since at least Mar 27, 2024
Jonathan Lim
Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Erasca, Inc. (Chairman & CEO, Director · Since at least Jul 15, 2021); Halozyme Therapeutics, Inc. (Chief Executive Officer, Director · Feb 5, 2007 – Feb 4, 2010 · Past)
Chairman and Co-Founder · Since at least Mar 27, 2024
Jami Rubin
Other companies: Relay Therapeutics, Inc. (Director · Since at least Jul 15, 2020); EQRx Inc (Chief Financial Officer · Dec 17, 2021 – Jan 1, 2023 · Past)
Chief Financial Officer · Mar 27, 2024 – Aug 19, 2024 · Past
Christian Hassig
Other companies: Sierra Oncology Inc (Chief Scientific Officer · Feb 1, 2018 – Mar 4, 2019 · Past)
Chief Scientific Officer · Since at least Mar 27, 2024
David Hinkle
Other companies: Receptos Inc (Sr. Dir. Fin, Cntrlr & CAO · May 8, 2013 – May 8, 2013 · Past)
Senior Vice President, Finance & Controller · Since at least Oct 11, 2024
Jessica Oien
Other companies: Cidara Therapeutics Inc (General Counsel & Secretary · Dec 3, 2018 – Mar 17, 2021 · Past)
Chief Legal Officer · Since at least Mar 27, 2024
Klaus W Wagner
Other companies: Inhibrx Inc (Chief Medical Officer · Aug 18, 2020 – Feb 16, 2021 · Past)
Chief Medical Officer · Mar 27, 2024 – Aug 19, 2024 · Past
Nancy Whiting
Other companies: Caribou Biosciences, Inc. (President and Chief Executive Officer · Since at least Aug 24, 2021)
Director · Since at least Mar 27, 2024
Neil Abdollahian
Other companies: Cidara Therapeutics Inc (Chief Business Officer · Jul 1, 2016 – Mar 17, 2021 · Past)
Chief Business Officer · Mar 27, 2024 – Aug 19, 2024 · Past
All 16 people
PersonSeat
Robert Doebele
Other companies: Rain Oncology Inc (See Remarks · Apr 22, 2021 – Jan 26, 2024 · Past)
Chief Medical Officer · Since at least Feb 3, 2025
Angela PietrofesoVice President, Clinical Operations · Since at least Nov 4, 2026
Christine BrennanDirector · Since at least Mar 27, 2024
James Jamie ChristensenDirector · Since at least Mar 27, 2024
Meredith WesleyChief Human Resources Officer · Since at least Nov 4, 2026
Zachary HornbyPresident & CEO, Director · Since at least Mar 27, 2024

Open People

Log in to ask 6ix AI your own questions about Boundless Bio, Inc.